AzTrials
AzTrials

Preterm Infant HealthNCT02146287

Preterm Infants: Light Effects on Health and Development

A study testing Cycled Light in people with Preterm Infant Health and Preterm Infant Development, run by Duke University.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Preterm babies cared for in the intensive care nursery are exposed to amounts of light that are very different from the exposures to an unborn baby or the newborn term baby. Currently many nurseries try to protect premature babies from too much light. Read more about this study

Who is it for?
Ages 23 to 28 weeks
What is being tested?
Cycled Light
Could I receive a placebo?
No, everyone receives an active treatment
How many people
121 participants
Where
No sites listed yet
Study dates
Jun 2003to Nov 2008
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 23 to 28 weeks
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Infants were < 7 days of age and were born at 28 weeks or < 28 weeks

Who cannot join

  • known anomalies associated with neurological or visual problems (e.g., congenital glaucoma, Down Syndrome)

About this study

Preterm babies cared for in the intensive care nursery are exposed to amounts of light that are very different from the exposures to an unborn baby or the newborn term baby. Currently many nurseries try to protect premature babies from too much light. They may also try to create light conditions of day and night like many parent homes. Some studies have shown improvements in health and development of babies cared for in nurseries that try to change light for premature babies.

Being tested
Cycled Light
Keywords
cycled light, preterm infants, infant neurodevelopment, infant sleep

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cycled LightOther

    Cycled light was provided in an 11-hour-on, 11-hour-off pattern. Daylight (240-700 lux) was provided with the incubator cover folded on top of the incubator allowing light in from four sides, or with the bassinet cover off during day hours (0730-1830). With the daylight range of 240-700 lux and limited access to natural light, excessive daylight was prevented.

    Continuous near darkness was provided as (5-30 lux) throughout the day except from 0630-0730 and 1830-1930, when lighting levels varied based on nursing care needs at the change of shift. Near-darkness (5-30 lux) was provided by using incubator (totally covered or with the front flap back) and bassinet covers, and dimming individual bedside light during the day (0730-1830) and night hours (1930-0630).

Study groups in NCT02146287
Study groupRoleWhat they receive
Early Cycled LightActive comparatorInfants received day night cycling of light on a 12-hour on and 12-hour off basis beginning at 28 weeks PMA
Receives: Other: Cycled Light
Late Cycled LightActive comparatorInfants received day night cycling of light on a 12-hour on and 12-hour off basis beginning at 36 weeks PMA
Receives: Other: Cycled Light

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Infant weight gain trajectory

    This measure was single blinded.

    Measured: weekly inpatient up to 52 weeks post menstral age (PMA) and at outpatient visits to 18 months

  2. Change in sleep development during hospitalization

    Change in the developmental pattern of four sleep wake states (active, quiet, transition, awake) were evaluated during hospitalization.

    Measured: Every three weeks up to 52 weeks PMA

  3. Change in sleep development after discharge home

    Change in the development of sleep and wake bouts were evaluated following hospital discharge until the infant reached 24 months PMA

    Measured: Every 5 months following hospital discharge up to 24 months PMA

  4. Mental Development

    Mental development was measured using the Bayley Scales of Infant Development.

    Measured: 9 months PMA

  5. Psychomotor Development

    Psychomotor Development was measured using the Bayley Scales of Infant Development

    Measured: 9 months PMA

  6. Mental Development

    Mental development was measured using the Bayley Scales of Infant Development.

    Measured: 18 months PMA

  7. Psychomotor Development

    Psychomotor Development was measured using the Bayley Scales of Infant Development

    Measured: 18 months PMA

Secondary outcomes (7)
  1. Length of Hospitalization in Days

    Length of hospitalization from birth until discharge home.

    Measured: At hospital discharge from 0 to 222 days

  2. Severity of Retinopathy of Prematurity (ROP)

    ROP change over time and degree of severity was assessed until 24 months PMA

    Measured: Up to 52 weeks

  3. visual acuity

    Measured: Measures at 12 months PMA

  4. Neurological development

    Neurological development was assessed by a neurological exam as either normal, suspect or abnormal and the presence of absence of Cerebral Palsy

    Measured: 9 months PMA

  5. Brainstorm Auditory Evoked Potentials

    Measured: 6 months

  6. Neurological development

    Neurological development was assessed by a neurological exam as either normal, suspect or abnormal and the presence of absence of Cerebral Palsy

    Measured: 18 months PMA

  7. Change in Retinopathy of Prematurity (ROP)

    ROP change over time and degree of severity was assessed until 24 months PMA

    Measured: Every two weeks during hospitalization after 30 weeks PMA up to 52 weeks PMA and during outpatient visits up to 24 months PMA

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2014 (estimated)
  2. Study startJun 2003
  3. Primary completionNov 2008
  4. Study completionNov 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
121 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02146287
Sponsor's protocol ID
Pro00011520
Other IDs
R01NR008044
Status last verified
Mar 2017
First submitted
21 May 2014
Last updated
29 Mar 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Morag I, Xiao YT, Bruschettini M. Cycled light in the intensive care unit for preterm and low birth weight infants. Cochrane Database Syst Rev. 2024 Dec 19;12(12):CD006982. doi: 10.1002/14651858.CD006982.pub5.

    PubMed 39699174
  • Park J, Knafl G, Thoyre S, Brandon D. Factors associated with feeding progression in extremely preterm infants. Nurs Res. 2015 May-Jun;64(3):159-67. doi: 10.1097/NNR.0000000000000093.

    PubMed 25932696

Questions about this trial

What is this clinical trial studying?

A study testing Cycled Light in people with Preterm Infant Health and Preterm Infant Development, run by Duke University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Mar 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Infant weight gain trajectory (time frame: weekly inpatient up to 52 weeks post menstral age (PMA) and at outpatient visits to 18 months). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02146287, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Mar 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in